Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Trulieve Cannabis (TCNNF) EBIAT (2020 - 2025)

Trulieve Cannabis has reported EBIAT over the past 6 years, most recently at -$38.0 million for Q4 2025.

  • Quarterly results put EBIAT at -$38.0 million for Q4 2025, up 31.14% from a year ago — trailing twelve months through Dec 2025 was -$112.4 million (up 26.32% YoY), and the annual figure for FY2025 was -$116.6 million, up 24.69%.
  • EBIAT for Q4 2025 was -$38.0 million at Trulieve Cannabis, down from -$28.8 million in the prior quarter.
  • Over the last five years, EBIAT for TCNNF hit a ceiling of $40.9 million in Q2 2021 and a floor of -$406.9 million in Q2 2023.
  • Median EBIAT over the past 5 years was -$32.3 million (2022), compared with a mean of -$50.3 million.
  • Peak annual rise in EBIAT hit 115.86% in 2021, while the deepest fall reached 2042.4% in 2021.
  • Trulieve Cannabis' EBIAT stood at -$59.0 million in 2021, then decreased by 13.09% to -$66.8 million in 2022, then surged by 47.9% to -$34.8 million in 2023, then crashed by 58.55% to -$55.2 million in 2024, then skyrocketed by 31.14% to -$38.0 million in 2025.
  • The last three reported values for EBIAT were -$38.0 million (Q4 2025), -$28.8 million (Q3 2025), and -$13.5 million (Q2 2025) per Business Quant data.